US Patent Issued to Cardurion Pharmaceuticals on Nov. 11 for "Monohydrate and crystalline forms of 6-[(3S,4S)-4-methyl-1-(pyrimidin-2-ylmethyl)pyrrolidin-3-yl-3-tetrahydropyran-4-yl-7H-imidazo[1,5-apyrazin-8-one" (British, Chinese Inventors)

ALEXANDRIA, Va., Nov. 11 -- United States Patent no. 12,466,832, issued on Nov. 11, was assigned to Cardurion Pharmaceuticals Inc. (Burlington, Mass.).

"Monohydrate and crystalline forms of 6-[(3S,4S)-4-methyl-1-(pyrimidin-2-ylmethyl)pyrrolidin-3-yl-3-tetrahydropyran-4-yl-7H-imidazo[1,5-apyrazin-8-one" was invented by Suzanne Buttar (Cambridge, Great Britain), Mateusz Pitak (Cambridge, Great Britain), Adam Ross Patterson (Cambridge, Great Britain), Samuel Alexander Stratford (Cambridge, Great Britain), Ioana Sovago (Cambridge, Great Britain), Jun Xu (Changzhou, China), Peng Zhou (Changzhou, China), Haojuan Wei (Changzhou, China) and Kuangchu Dai (Changzhou, China).

According to the abstract* released by the U.S. Patent & Trademark Office:...